Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies-Reference-Cited by-同舟云学术

Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies

Published:2006-12 Issue:18 Volume:7 Page:2465-2479
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Dixon J Michael

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.7.18.2465

Reference122 articles.

1. DOWSETT M: Rationale for the endocrine treatment of breast cancer. In:Endocrine Aspects of Breast Cancer. Dowsett M (Ed) Parthenon, Camforth, UK (1992):11-24.

2. Retrospective Analysis of Time to Recurrence in the ATAC Trial According to Hormone Receptor Status: An Hypothesis-Generating Study

3. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials

4. HELLMAN S, HARRIS JR: Natural history of breast cancer. In:Diseases of the Breast. Harris JRet al.(Eds) Lippincott Williams & Wilkins, Philadelphia, PA, USA (2000):407-423.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testolactone: The Rise and Fall of a Drug;Drugs and Drug Candidates;2023-02-04

2. SEOM clinical guidelines for using molecular markers in clinical practice;Clinical and Translational Oncology;2011-08

3. Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates;ChemMedChem;2011-05-23

4. Bicyclic Derivatives of the Potent Dual Aromatase-Steroid Sulfatase Inhibitor 2-Bromo-4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: Synthesis, SAR, Crystal Structure, and in vitro and in vivo Activities;ChemMedChem;2010-07-14

5. A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor;Clinical Cancer Research;2008-10-15